AstraZeneca approves use of its Covid-19 vaccines that were delivered to Latvia in lower temperature than required

  • 2021-02-08
  • LETA/TBT Staff

RIGA - AstraZeneca pharmaceutical company has confirmed that the batch of its coronavirus vaccines, delivered to Latvia last Sunday, can be sent from the logistics company's storage facility to vaccination service providers, LETA was told at the State Agency of Medicines. 

As reported, before further distributing the AstraZeneca vaccines that were delivered to Latvia on Sunday, Latvia was waiting for the manufacturer's opinion because the delivered vaccines had been stored in a temperature that is half a degree lower than required in the description.

Now, it has been confirmed that the divergence from the transportation temperature has no impact on the quality of the vaccines. 

Vakcina logistics services provider will schedule the distribution of the vaccine doses and contact all the vaccination service providers waiting for the AstraZeneca vaccine. 

On Sunday, the first batch of AstraZeneca Covid-19 vaccines was delivered to storehouse of Vakcina logistics company.

The temperature on delivery was by half a degree lower that required in the description of the vaccine - 2-8 degrees C. As a result, Latvia now is expecting manufacturer's opinion for further use of the vaccines to make sure that their efficiency has not been affected.

The supplier selected by the manufacturer is responsible for the delivery procedure, including the temperature regime, until the vaccines are delivered to a storehouse in Latvia.

Latvia took delivery of the first 7,200 AstraZeneca vaccines on Sunday.